Medicus Pharma (MDCX) Other Operating Expenses (2024 - 2025)

Medicus Pharma (MDCX) reported Other Operating Expenses of -$996039.0 for Q4 2025, up 40.88% quarter-over-quarter from -$1.7 million in Q3 2025.

Medicus Pharma (MDCX) Other Operating Expenses (2024 - 2025) Analysis & Trends

Medicus Pharma has reported Other Operating Expenses for 2 years, with the latest figure at -$996039.0 in Q4 2025.

For the quarter ending Q4 2025, Other Operating Expenses changed N/A year-over-year to -$996039.0; the trailing twelve-month figure through Dec 2025 stood at -$2.7 million (down 575.2% YoY), and the FY2025 full-year result was $7.7 million, changed N/A from the prior year.
Other Operating Expenses for Q4 2025 stood at -$996039.0, up from -$1.7 million in the prior quarter.
The five-year high for Other Operating Expenses was $564145.0 in Q3 2024, with the low at -$1.7 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Gsk	92,316,836.42 Bn	92,316,831.46 Bn	7.76 Bn
2	Eli Lilly	983.57 Bn	978.29 Bn	16.22 Bn
3	Johnson & Johnson	553.56 Bn	531.50 Bn	15.96 Bn
4	AbbVie	383.35 Bn	374.00 Bn	10.78 Bn
5	Merck	281.71 Bn	276.06 Bn	12.09 Bn
6	Amgen	182.20 Bn	170.16 Bn	5.87 Bn
7	Gilead Sciences	153.71 Bn	145.98 Bn	5.52 Bn
8	Pfizer	143.75 Bn	130.98 Bn	-1.21 Bn
9	Bristol Myers Squibb	109.71 Bn	99.25 Bn	8.07 Bn
10	Medicus Pharma	7.87 Mn	7.98 Mn	-

Download Data